FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/10/010240 [Registered on: 30/10/2017] Trial Registered Retrospectively
Last Modified On: 27/10/2017
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Study of blind tracheal intubation through three supraglottic airway devices: ILMA(Intubating Laryngeal Mask Airway),I-Gel and Ambu AuraGain in adults. 
Scientific Title of Study   Comparative evaluation of three supraglottic airway devices: ILMA(Intubating Laryngeal Mask Airway),I-Gel and Ambu AuraGain for blind tracheal intubation in adults. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Riniki Sarma 
Designation  post graduate student 
Affiliation  Maulana Azad Medical College 
Address  Room no 25, Lok Nayak resident doctors hostel (LNRDH), Maulana Azad Medical College, Bahadur Shah Zafar marg, New Delhi

New Delhi
DELHI
110002
India 
Phone  8447456976  
Fax    
Email  riniki_rs@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rakesh Kumar 
Designation  Supervisor/ Guide 
Affiliation  Maulana Azad Medical College 
Address  Room no 302, Department of Anesthesiology and critical care,3rd floor, B.L.Taneja Block, Maulana Azad Medical College, Bahadur Shah Zafar marg, New Delhi

New Delhi
DELHI
110002
India 
Phone  9968604214  
Fax    
Email  rakeshrampal@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Riniki Sarma 
Designation  post graduate student 
Affiliation  Maulana Azad Medical College 
Address  Room no 25, Lok Nayak resident doctors hostel (LNRDH), Maulana Azad Medical College, Bahadur Shah Zafar marg, New Delhi

New Delhi
DELHI
110002
India 
Phone  8447456976  
Fax    
Email  riniki_rs@hotmail.com  
 
Source of Monetary or Material Support  
Lok Nayak Hospital, Bahadur shah Zafar marg, New Delhi-110002 
 
Primary Sponsor  
Name  Lok Nayak Hospital 
Address  Lok Nayak Hospital,Bahadur Shah Zafar Marg, New Delhi-110002 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Riniki Sarma  Lok Nayak hospital  Room no 302,Department of anesthesiology and critical care, B.L.Taneja block, Maulana Azad Medical College Bahadur Shah Zafar Marg, New Delhi-110002
New Delhi
DELHI 
8447456976

riniki_rs@hotmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Maulana Azad Medical College institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Patients undergoing elective surgery under general anesthesia requiring endotracheal intubation,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group IL, group IG, group AG  Group IL- patients where ILMA was used for blind tracheal intubation Group IG- patients where Igel was used for blind tracheal intubation Group AG- patients where Ambu auragain was used for blind endotracheal intubation 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  18-65yrs age; ASA1,2,3; Mallampalli class 1-2; thyromental distance more than 6cm; inter incisor gap more than 3cm; range of neck movement more than 90degree; Bmi less than 30kg/m2 
 
ExclusionCriteria 
Details  Pregnant patients; congenital or acquired airway abnormality; patients with increased risk of aspiration; patients with GERD 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   On-site computer system 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Successful intubation in first attempt  All successful blind intubation after 1 attempt 
 
Secondary Outcome  
Outcome  TimePoints 
Overall successful intubation in two attempts  All successful blind intubation after 2 attempts 
Time of insertion in successful attempt  Time required for successful intubation in 1st or 2nd attempt 
Ease of insertion of device and endotracheal tube  After successful insertion of device and endotracheal tube 
Post operative complications  post operatively after 2 hours and 24 hours 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "95"
Final Enrollment numbers achieved (India)="95" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/12/2015 
Date of Study Completion (India) 30/12/2016 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Title- Comparative evaluation of three supraglottic airway devices: intubating laryngeal mask airway (ILMA), I-gel and Ambu AuraGain for blind tracheal intubation in adults.

Background- Although fibreoptic endoscopy is the method of choice for tracheal intubation through a supraglottic airway device (SAD), a fibrescope may not always be available. Hence, there is need to evaluate the SADs for blind tracheal intubation through these. Our study assesses three supraglottic airway devices, intubating laryngeal mask airway (ILMA), i-gel and Ambu AuraGain for blind tracheal intubation in adults

Materials and methods- After taking instituitional review board approval, this prospective randomised study was conducted in the department o f anesthesiology, MAMC and associated Lok Nayak Hospital, New Delhi. Ninety adults undergoing elective surgery under general anaesthesia was randomised into three equal groups. After a standardised induction of anesthesia, the group specific SAD was inserted and on achieving adequate ventilation with the device, blind tracheal intubation was attempted. Success rates of blind tracheal intubation through the SADs, ease of device and ET tube insertion and post operative complications (secondary outcome criteria) were evaluated. Data were analysed using SPSS version 17.0 and p<0.05 was considered statistically significant.

Results- There was no difference in the incidence of adequate ventilation with any of the SAD. The success rate of tracheal intubation in 1st attempt was 86.67% in ILMA group and 26.67% in i-gel group. The success rate of tracheal intubation was 100% in ILMA group and 40% in i-gel group after both the attempts. It was not possible to intubate through Ambu auraGain in both attempts. Time taken for successful tracheal intubation in ILMA and i-gel did not differ significantly (p value=0.205). Post operative complications also did not differ significantly in the three groups.

Conclusion- Out of the three, ILMA is the best device for blind tracheal intubation.
 
Close